Investcorp has acquired Armacell International GmbH in a secondary buyout from Gilde Buy-Out Fund and funds managed and advised by CVC Capital Partners. No further terms of the transaction have been disclosed.
Managing director Craig Ferguson discusses accelerated deployment activity during the pandemic and plans to scale up the PE allocation by 2025
Fund has a target of $600m, which it plans to reach by next year, according to Kommersant
Existing investors including Institut Català de Finances also take part in the financing
Biotech company initially raised €12m in December 2018